Back
GDS Holdings Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
23
GDS
GDS Holdings
Last Price:
$25.23
Seasonality Move:
6.71%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$268.29
Seasonality Move:
7.6%
Sell
23
GDS Holdings (GDS)
is a Sell
Is GDS Holdings a Buy, Sell or Hold?
-
The current GDS Holdings [GDS] share price is $26.17. The Score for GDS is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
GDS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $271.02. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GDS Stock Price Chart
What is GDS Holdings's stock price today?
-
The GDS Holdings share price today is $26.17Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDS is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $271.02The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
GDS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.7 | Sell |
| Relative Strength Index (14 RSI): | 36.67 | Sell |
| Chaikin Money Flow: | -1255890 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.59 - 41.03) | Sell |
| Bollinger Bands (100): | (18.94 - 33.28) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.53 | Buy |
| Relative Strength Index (14 RSI): | 57.28 | Buy |
| Chaikin Money Flow: | 106003 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (238.42 - 267) | Buy |
| Bollinger Bands (100): | (240.58 - 270.64) | Buy |
GDS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.93 | Sell |
| 20-day SMA: | 33.36 | Sell |
| 50-day SMA: | 30.75 | Sell |
| 200-day SMA: | 20.4 | Buy |
| 8-day EMA: | 28.9 | Sell |
| 20-day EMA: | 31.69 | Sell |
| 50-day EMA: | 30.77 | Sell |
| 200-day EMA: | 22.42 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 268.31 | Buy |
| 20-day SMA: | 253.84 | Buy |
| 50-day SMA: | 259.68 | Buy |
| 200-day SMA: | 253.36 | Buy |
| 8-day EMA: | 268.69 | Buy |
| 20-day EMA: | 260.57 | Buy |
| 50-day EMA: | 257.45 | Buy |
| 200-day EMA: | 244.33 | Buy |
GDS Holdings Earnings Growth & GDS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $0.43 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
GDS Holdings Technical Analysis
| Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||